Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Catalyst Bio (NQ: CBIO )

6.860 USD +0.200 (+3.00%)
Official Closing Price Updated: 4:46 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 108,766
Open 6.660
Bid (Size) 6.250 (89)
Ask (Size) 6.900 (5)
Prev. Close 6.660
Today's Range 6.570 - 6.890
52wk Range 3.430 - 8.940
Shares Outstanding 11,935,169
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress
From GlobeNewswire News Releases
Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital
From GlobeNewswire News Releases

Performance

YTD
+11.36%
+11.36%
1 Month
+4.89%
+4.89%
3 Month
+30.67%
+30.67%
6 Month
+20.14%
+20.14%
1 Year
-4.59%
-4.59%

More News

Read More
Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference
From GlobeNewswire News Releases
Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs
From GlobeNewswire News Releases
Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors
From GlobeNewswire News Releases
Catalyst Biosciences to Present at 32nd Annual Piper Sandler Virtual Healthcare Conference
From GlobeNewswire News Releases
Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference
From GlobeNewswire News Releases
Catalyst Biosciences Reports Third Quarter 2020 Operating & Financial Results and Provides a Corporate Update
From GlobeNewswire News Releases
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
From GlobeNewswire News Releases
Catalyst Biosciences Receives US Patent for its Anti-Complement Factor 3 Portfolio of Engineered Proteases
From GlobeNewswire News Releases
Catalyst Biosciences to Present at the Stifel Immunology and Inflammation Summit
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.